ArticleBMC microbiology2026
Gut bacterial characteristics in children with autism spectrum disorder according to symptom severity: a cross-sectional study.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAutism spectrum disorder (ASD) is associated with alterations in gut microbiota. The gut-brain axis, which involves bidirectional communication between the gastrointestinal tract and the central nervous system, has been implicated in the pathophysiology of ASD. This study aimed to investigate the relationship between gut microbiota characteristics and symptom severity in children with ASD.
methodsThis cross-sectional study enrolled a total of 81 children with ASD aged 3-12 years, who were divided into mild-to-moderate (n = 35) and severe (n = 46) groups based on Childhood Autism Rating Scale scores. Fecal samples were collected for 16 S rRNA gene sequencing. Alpha diversity, beta diversity, and species composition were analyzed using R software. Linear Discriminant Analysis Effect Size (LEfSe) with a threshold of LDA score ≥ 2.0 and P < 0.05 was used to identify differentially abundant taxa.
resultsThe severe ASD group showed significantly lower Shannon index [4.04 (3.74-4.33) vs. 3.82 (3.40-4.23); P = 0.047] and Simpson index [0.95 (0.93-0.96) vs. 0.92 (0.90-0.96); P = 0.012] compared with the mild-to-moderate ASD group. Beta diversity analysis revealed significant separation between groups (PERMANOVA, R² = 0.048, P = 0.003). At the phylum level, the severe ASD group showed decreased Firmicutes (56.92%→47.46%) and increased Proteobacteria (5.92%→14.46%). At the family level, Enterobacteriaceae was increased (4.64%→13.08%), while Selenomonadaceae (2.64%→0.80%), Veillonellaceae (3.99%→2.70%), and Coriobacteriaceae (3.90%→2.36%) were decreased. At the genus level, Klebsiella showed a 2.8-fold increase (1.81%→5.06%), while Faecalibacterium (14.81%→11.84%) and Dialister (2.85%→1.95%) were decreased. LEfSe identified 11 differentially abundant taxa (LDA score ≥ 2.0, P < 0.05), with 10 taxa enriched in the mild-to-moderate ASD group, including Firmicutes (LDA = 4.69, P = 0.003), Coriobacteriia (LDA = 3.95, P = 0.026), Coriobacteriales (LDA = 3.95, P = 0.026), Bacteroides ovatus (LDA = 3.10, P = 0.048), and Sutterella (LDA = 2.65, P = 0.030), and several uncultured taxa. Only Fusobacteriaceae (family) was enriched in the severe ASD group (LDA = 3.40, P = 0.043).
conclusionsGut bacterial dysbiosis in ASD children is characterized by reduced diversity and altered composition, with more pronounced abnormalities in the severe ASD group. However, this study only evaluated bacterial communities (not fungi or viruses), and the cross-sectional design does not support causal inferences. These findings suggest that microbiota modulation may represent a potential therapeutic approach for ASD, though causal relationships remain to be established in longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.